The recent news of MEDV to embark in the Telehealth and wellness market + the addition of Blowfish technology are game changers and, the stock will command a premium as stocks in this field trade at 30x earnings and, 10x sales because it is RECURRING income.

The covid19 testing cubes put us on the map but it will be telehealth and blowfish that carry us to the BILLION $$$ market cap. 

The biggest asset which MEDV is acquiring from the covid19 cubes is a LUCRATIVE PATIENT LIST to which it can begin to offer many other services.

What is fascinating from the telehealth market is that it represents RECURRING income.

Blowfish technolgy is a catch all technology in that all types of tests can be done, you are not limited to covid19.  Pfizer was interested for a reason. 

It goes without saying that covid19 with its many variants will continue to be with us for years and, testing by itself will not go away, the cost of having the virus resurface where it cripples economies and hospitals is simply too high.    Given that the WHO has already confirmed that he covid19 virus will become endemic meaing to be with us forever, testing will always be required until decades later it becomes like the common cold.

In the meantime, MEDV will rake in with covid19 as they expand their business towards the more lucrative and recurring telehealth and blowfish market.

Based on sales of say $ 50 million per year from telehealth alone, we would command a market cap of $ 1.5 billion, that would mean a stock price of $ 5 per share on this alone. 

PS:  I am following the results from Isreal very closely as they have close to 25% of the population vaccinated with Pfizer, double dose to date.   They are doing it properly.   And what is surprising is that the infection rate still remains pretty high and, deaths occurring on a daily basis, even though most of the vunerable crowd has been vaccinated.  So this begs the question, is the vaccine working????

MPO